Spirair Information

Challenging conventional thinking to create meaningful innovations in ENT. Spirair is an early-stage medical device company shaping the future of ENT through clinically-driven innovation and modern technology. We believe meaningful advancements should elevate physician performance and patient experience equally. Our minimally invasive, next-generation solutions are designed around the needs of today’s physicians and patients, improving procedural efficiency and enhancing patient satisfaction without compromise. Spirair got its start in the Stanford Biodesign Innovation Fellowship, a program that equips aspiring innovators with a proven, repeatable process to identify important health-related needs, invent novel health technologies to address them, and prepare to implement those products into patient care. Founders James Kintzing, Ph.D. and Brandon McCutcheon, M.D. were co-fellows in the program and identified an opportunity in the ENT space when they discovered the unmet need for a minimally invasive nasal septal deviation correction therapy to help address nasal airway obstruction. Please note: Spirair only sends hiring-related emails from addresses ending in @ spirair dot com email address.